BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 16526206)

  • 1. [Antiphospholipid syndrome--the description of two cases].
    Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
    Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
    Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
    Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical spectrum of the antiphospholipid syndrome].
    Chábová V; Tesar V; Zabka J; Bartůnková J; Stejskalová A; Dostál C; Valenta J; Rychlík I
    Cas Lek Cesk; 1997 Apr; 136(8):253-5. PubMed ID: 9264870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
    Tarr T; Muzes G; Pitlik E; Lakos G; Csépány T; Soltész P; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2005 Jan; 146(5):203-7. PubMed ID: 15773587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two clinical cases of antiphospholipid syndrome].
    Kartvelishvili E; Astvatsaturova T
    Georgian Med News; 2011 Jan; (190):37-41. PubMed ID: 21346266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 61 patients with antiphospholipid syndrome].
    Leng XM; Liu XM; Ai MX; Zeng XF; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1367-70. PubMed ID: 15387947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasculopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome].
    Alekberova ZS; Reshetniak TM; Rodenska-Lopovok SG; Aleksandrova EN; Kalashnikova LA; Nasonov EL; Mach ES; Nasonova VA
    Ter Arkh; 1995; 67(5):41-4. PubMed ID: 7638777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.